FlowAssist Pouch will help to improve the skin condition of ostomy pouch users, while introducing novel design features, dramatically improving their lifestyle and management of their conditionbroad
FlowAssist Pouch · Horizon Europe grant · 2023-01-01–2024-12-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2022-ACCELERATOR-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2022-ACCELERATORCHALLENGES-01. CORDIS record →
Objective
Ostoform has developed and patented a new Class I medical technology – FLOWASSIST – by combing a non-absorbent material with an absorbent material (hydrocolloid). The non-absorbent material comprises a flexible spout, positioned beneath the patient’s stoma and is combined with hydrocolloid adhesive to keep the spout in place. This hybrid design directs stoma output away from the patient’s skin and into the pouch. The spout prevents output from being absorbed so the hydrocolloid material does not break down. This means that the appliance lasts for longer, the skin is protected for longer and the risk of leaks and skin complications is significantly reduced.The Ostoform Seal with FLOWASSIST has been successfully developed and commercialised through the H2020 SME Instrument. Ostoform now plans to develop the Ostoform Pouch with the same FLOWASSIST technology. As the ostomy pouch market is larger than the seal market, the novel pouch will increase market opportunity and company value.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| OSTOFORM LIMITED | IE | coordinator | €2,499,901 | Yes |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.